Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes

Overview of attention for article published in BMC Musculoskeletal Disorders, November 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,017 followers.

RT @Cryoniss_Ltd: Thrombospondin-1 may constitute a therapeutic approach for patients with dysferlinopathies. #lifesciences #drugdiscovery…

Thrombospondin-1 may constitute a therapeutic approach for patients with dysferlinopathies. #lifesciences #drugdiscovery https://t.co/ygNPMnHUHQ https://t.co/SCtKC5Vw2z

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.